Echo Therapeutics Inc. (ECTE) drummed up about $3 million in a private stock sale.
The Franklin, Mass.-based company, which is developing a non-invasive, wireless transdermal continuous glucose monitoring system, said it sold roughly 2.37 million share for $1.25 each, and issued about 2.2 million warrants with a $2.00 exercise price.